Skip to main content
Log in

CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke

  • Short Communication
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Experimental cerebral ischemic stroke is exacerbated by inflammatory T-cells and is accompanied by systemic increases in CD4+CD25+Foxp3+ regulatory T-cells (Treg). To determine their effect on ischemic brain injury, Treg were depleted in Foxp3DTR mice prior to stroke induction. In contrast to a recent Nature Medicine report, our results demonstrate unequivocally that Treg depletion did not affect stroke infarct volume, thus failing to implicate this regulatory pathway in limiting stroke damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  • Dirnagl U, Klehmet J, Braun J, Harms H, Meisel C, Ziemssen T, Prass K, Meisel A (2007) Stroke induced immunodepression, experimental evidence and clinical relevance. Stroke 38:770–773

    Article  PubMed  Google Scholar 

  • Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T cells prevent catastrophic autoimmunology throughout the lifespan of mice. Nat Immunol 8:191–197

    Article  PubMed  CAS  Google Scholar 

  • Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15:192–199

    Article  PubMed  CAS  Google Scholar 

  • Offner H, Subramanian S, Parker S, Afentoulis M, Vandenbark A, Hurn P (2006a) Experimental stroke induces massive rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26:654–665

    Article  PubMed  CAS  Google Scholar 

  • Offner H, Subramanian S, Parker S, Wang C, Afentoulis M, Lewis A, Vandenbark A, Hurn P (2006b) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176:6523–6531

    PubMed  CAS  Google Scholar 

  • Sacco RL, Chong JI, Prabhakaran S, Elkind MS (2007) Experimental treatments for acute ischaemic stroke. Lancet 369:331–341

    Article  PubMed  CAS  Google Scholar 

  • Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T (2006) Foxp + CD25 + CD4+ natural T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212:8–27

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Dr. Sushmita Sinha, Ms. Sandhya Subramanian and Dr. Suzan Dziennis for helpful discussions and Ms. Eva Niehaus and Heather Hoem for assistance in preparing the manuscript. This work was supported by NIH grant NR03521 and the Biomedical Laboratory R&D Service, Department of Veterans Affairs.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Halina Offner.

Additional information

Xuefang Ren and Kozaburo Akiyoshi contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ren, X., Akiyoshi, K., Vandenbark, A.A. et al. CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis 26, 87–90 (2011). https://doi.org/10.1007/s11011-010-9226-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-010-9226-6

Keywords

Navigation